(Q41719281)

8 October 2017

1 reference

title

Inflammation and TGF beta 1: lessons from the TGF beta 1 null mouse (English)

1 reference

8 October 2017

A B Kulkarni

1

1 reference

8 October 2017

S Karlsson

series ordinal

2

1 reference

8 October 2017

publication date

1 September 1997

1 reference

8 October 2017

published in

Research in Immunology

1 reference

8 October 2017

volume

148

1 reference

8 October 2017

issue

7

1 reference

8 October 2017

page(s)

453-456

1 reference

Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice.

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Maternal rescue of transforming growth factor-beta 1 null mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Transforming growth factor-beta1-deficient mice: identification of isoform-specific activities in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

The transforming growth factor-beta family

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Transforming growth factor beta: a matter of life and death

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Autoimmune diseases: the failure of self tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2897%2982669-7

7 January 2021

10.1016/S0923-2494(97)82669-7

Identifiers

DOI

1 reference

8 October 2017

1 reference